ClinicalTrials.gg
Drug

Meropenem clinical trials

Also written Merrem and Meronem.

studies test it
62
open now
7
in phase 3
15
first study started
2001

Counted the way a researcher would: Meropenem with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Meropenem is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Meropenem studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Jun 1996 · MERREM IV · NDA 050706 (FDA, Drugs@FDA)
European Union
20 Nov 2018 · Vaborem · EMEA/H/C/004669 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Meropenem
39
Meropenem 1000 mg
4
Meropenem Infusion
3
Meropenem Injection
3
Meropenem trihydrate
2

Brand

Merrem
6
Meronem
4
Merrem I.V.
1

Studies by the year they started

62 studies that test it; most in 2012 (6)

Studies that test Meropenem, by start year
YearStudies
20011
20022
20031
20042
20062
20072
20082
20091
20105
20126
20134
20143
20151
20163
20171
20184
20193
20201
20215
20222
20243
20255
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
7
Phase 2
14
Phase 3
15
Phase 4
26
No phase
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 52

Pfizer (4) · TASK Applied Science (3) · Sutep Jaruratanasirikul (2) · PENTA Foundation (2) · Hellenic Institute for the Study of Sepsis (2) · Beni-Suef University (1) · Ain Shams University (1) · Sheikh Zayed Medical College (1)

Often tested with

Tested in the same studies.

Piperacillin, Tazobactam Drug Combination (7) · Ceftazidime (4) · Cefepime (3) · Tigecycline (3) · Vancomycin (3) · Amikacin (2) · Aztreonam (2) · Ertapenem (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Meropenem is the comparator. A study of two new drugs counts under both.

  • 1XNW4107 · Evopoint Biosciences Inc.
Reaching primary completion within a year · 3

Studies that test Meropenem.

Studies

Open first, then newest update. How each study uses Meropenem is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 62

See all 62 studies that test Meropenem →

Given beside what is tested · 19 — Meropenem is usual care or a partner of the new treatment
As the comparator · 40 — what is tested is compared with Meropenem

Showing 20 of 40.

Codes

What other systems call Meropenem · ClinicalTrials.gg INT006796

  • MeSH (NLM) D000077731MeropenemConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) FV9J3JU8B1MEROPENEMConfirmed FDA, NLM, Wikidata
  • RxNorm 29561Confirmed FDA, Wikidata
  • Wikidata Q47495774meropenem trihydrateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1160MeropenemConfirmed FDA, Wikidata
  • DrugBank DBSALT002823One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.